Renal denervation- its current status & future prospects for management of Hypertension
Open Access
- 3 September 2020
- journal article
- Published by Peertechz Publications Private Limited in Archives of Clinical Hypertension
- Vol. 6 (1), 019-021
- https://doi.org/10.17352/ach.000026
Abstract
Miguel Devronsky proposed in 1970’s a theory explaining mechanism of action of ingested pure protein; so-called protein-diet, as follows:Keywords
This publication has 16 references indexed in Scilit:
- A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designsAmerican Heart Journal, 2017
- Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysisThe Lancet, 2015
- Reinnervation of Renal Afferent and Efferent Nerves at 5.5 and 11 Months After Catheter-Based Radiofrequency Renal Denervation In SheepHypertension, 2015
- Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trialThe Lancet, 2015
- A Controlled Trial of Renal Denervation for Resistant HypertensionThe New England Journal of Medicine, 2014
- Sympathetic Nervous System Moves Toward Center Stage in Cardiovascular MedicineHypertension, 2014
- Adherence to Medications: Insights Arising from Studies on the Unreliable Link Between Prescribed and Actual Drug Dosing HistoriesAnnual Review of Pharmacology and Toxicology, 2012
- Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trialThe Lancet, 2010
- Sympathetic Nervous System and Blood Pressure in HumansHypertension, 2010
- Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort studyThe Lancet, 2009